Psilocybin Is Headed for the Mainstream — It’s Bringing the Problems of Big Pharma With It

The psychedelic community is torn over the growing interest in developing medical versions of a drug that may even help treatment-resistant depression

Denver, CO —May 19, 2019: Mazatec psilocybin mushrooms are ready for harvest in their growing tub. Photo: Joe Amon/MediaNews Group/The Denver Post via Getty